251 results on '"Filler, Guido"'
Search Results
2. Should urinary CXCL10/creatinine be measured for kidney transplantation?
3. The ongoing need to improve long‐term patient survival of pediatric solid organ recipients
4. Impaired kidney function >90 days determines long‐term kidney outcomes
5. Is there a case for early treatment with IVIG for BK transplant nephropathy?
6. Practice recommendations: A new type of article in Pediatric Transplantation
7. Practice recommendations for the monitoring of renal function in pediatric non-renal organ transplant recipients
8. Minimum mycophenolic acid levels are associated with donor-specific antibody formation
9. What is the intrapatient variability of mycophenolic acid trough levels?
10. The merits of sequential transplantation for hyperoxaluria type I
11. Finding the optimal therapeutic window for tacrolimus
12. Marginal parent donors—Process and ethics
13. The problem with generic immunosuppressants
14. Using individual DSA titers to assess for accommodation after late humoral rejection
15. Combined liver–kidney transplantation for hyperoxaluria type II?
16. High prevalence of renal dysfunction also after small bowel transplantation
17. Ω3 fatty acids may reduce hyperlipidemia in pediatric renal transplant recipients
18. High prevalence of hypertension and renal glomerular and tubular dysfunction after orthotopic liver transplantation
19. Are fibroblast growth factor 23 concentrations in renal transplant patients different from non-transplanted chronic kidney disease patients?
20. Monitoring and improving renal outcomes after heart transplantation
21. Challenges in pediatric transplantation: The impact of chronic kidney disease and cardiovascular risk factors on long-term outcomes and recommended management strategies
22. Lower prevalence of aortic dilatation among preemptive pediatric renal transplant recipients – A cross‐sectional cohort study
23. High depression rates among pediatric renal replacement therapy patients: A cross‐sectional study
24. Limited sampling strategies for sirolimus after pediatric renal transplantation
25. Intravenous immunoglobulin as rescue therapy for BK virus nephropathy
26. Characterization of sirolimus metabolites in pediatric solid organ transplant recipients
27. High prevalence of chronic kidney disease in pediatric solid organ transplantation
28. Myfortic in pediatric transplantation
29. How to monitor renal function in pediatric solid organ transplant recipients
30. Complications of chronic kidney disease in children post-renal transplantation – A single center experience
31. Sirolimus is not always responsible for new-onset proteinuria after conversion for chronic allograft nephropathy
32. Unexpectedly high inter- and intrapatient variability of Ganciclovir levels in children
33. Cyclosporin twice or three times daily dosing in pediatric transplant patients – It is not the same!
34. Renal transplantation: Literature review 2004–2005
35. Preventing sensitization with mycophenolate mofetil in a pediatric kidney recipient
36. How to assess for impaired glucose tolerance before transplantation and should these results influence the choice of calcineurin inhibitors?
37. Caregiver attitudes towards gastrostomy removal after renal transplantation
38. Tissue viral DNA is associated with chronic allograft nephropathy
39. Four-year data after pediatric renal transplantation: A randomized trial of tacrolimus vs. cyclosporin microemulsion
40. Intra-individual variation of cystatin C and creatinine in pediatric solid organ transplant recipients
41. Drug interactions between mycophenol ate and cyclosporine
42. Is decreased bone mineral density in pediatric transplant recipients really a problem?
43. Glomerular filtration rate as a putative ‘surrogate end-point’ for renal transplant clinical trials in children
44. Cystatin C should be measured in pediatric renal transplant patients!
45. Cyclosporin A monitoring and AUC determination — where do we go?
46. G protein β3 subunit 825T genotype is not associated with differing outcome in pediatric renal transplant recipients
47. The emerging role of gene polymorphisms determining outcome after solid-organ transplantation
48. Renin angiotensin system gene polymorphisms in pediatric renal transplant recipients
49. Kidney disease and organ transplantation in methylmalonic acidaemia
50. Appreciating the need for greater understanding of the pharmacokinetics of drugs in children and adolescents
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.